Polaris attributed the anticipated growth primarily to aging populations, higher prevalence of cardiovascular and neurological diseases, and technological advancements.
Metabolic clinical laboratory testing was the largest market segment of all lab test types in the study, while central laboratories represented the largest market share based on end-use.
